Reactions 1680, p121 - 2 Dec 2017 Severe allergic reaction: case report A 61-year-old man developed severe allergic reaction following treatment with sequential docetaxel chemotherapy [route, time to reaction onset and outcome not stated]. The man, who had breast cancer originating in an accessory mammary gland in the axilla, started receiving treatment with four courses of FEC chemotherapy (fluorouracil, epirubicin and cyclophosphamide) followed by sequential docetaxel 75 mg/m chemotherapy. Later on, his docetaxel chemotherapy was stopped due to severe allergic reaction and he received two additional courses of FEC chemotherapy. Author comment: "[S]equential docetaxel chemotherapy at 75 mg/m2 was discontinued due to a severe allergic reaction." Yamamura J, et al. Male breast cancer originating in an accessory mammary gland in the Axilla: A case report. Case Reports in Medicine 2012: 286210, 2012. Available from: URL: http://doi.org/10.1155/2012/286210 - Japan 803284647 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera